摘要
目的:探讨腺病毒介导的组织因子途径抑制物-2(TFPI-2)基因转染对喉鳞状细胞癌细胞侵袭的影响。方法:将TFPI-2基因(Ad-TFPI-2)体外转染喉鳞状细胞癌Hep-2细胞,运用Western-blot检测Hep-2细胞TFPI-2蛋白表达,运用Boyden小室实验检测Hep-2细胞的侵袭能力的变化,将感染Ad-TFPI-2的Hep-2细胞接种于裸鼠皮下观察其成瘤能力。结果:经酶切、测序等方法的鉴定证实了Ad-TFPI-2的正确性,病毒滴度为2.8×1013PFU/L,Western-blot结果显示TFPI-2蛋白在实验组Hep-2细胞表达增高,Boyden小室实验显示实验组Hep-2细胞的侵袭能力降低,裸鼠成瘤实验显示实验组Hep-2细胞成瘤能力下降。结论:TFPI-2重组腺病毒能够有效地抑制人喉鳞状细胞癌Hep-2细胞的侵袭能力。
Objective:To study the effects of adenovirus-mediated tissue factor pathway inhibitor-2 gene on the invasion of laryngeal squamous cancer. Method: Ad-TFPI-2 was transfected into laryngeal squamous cancer (Hep- 2) cell. Western-blot was used to test the TFPI-2 protein expression and Boyden Chamber experiment was used to examine the invasive ability of Hep-2 cells. Furthermore, the Ad-TFPI-2 infected Hep-2 cells were subcutaneously inoculated in nude mice and the tumor formation capability were observed. Result: Ad-TFPI-2 was identified correctly by endonuclease and sequencing and the virus titer was 2. 8 X 10)a PFU/L. In the Hep-2 cells of treated group, the TFPI-2 protein expression was increased while the invasive capability was descent. The tumor formation capability was also decreased in the treated group nude mouse model. Conelusion:TFPI-2 recombinant adenovirus can effectively inhibit the invasive capability of laryngeal squamous cancer.
出处
《临床耳鼻咽喉头颈外科杂志》
CAS
CSCD
北大核心
2008年第7期315-317,共3页
Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金
国家自然科学基金资助项目(No:30540010)
黑龙江省青年基金资助项目(No:QC06C054)
哈尔滨医科大学附属第二医院博士启动基金
中国博士后科学基金资助项目(No:20070410920)
关键词
喉肿瘤
癌
鳞状细胞
腺病毒
组织因子途径抑制物-2基因
基因治疗
Laryngeal neoplasms
Carcinoma, squamous cell
Adenovirus
Tissue factor pathway inhibitor-2
Gene therapy